TLR5 agonist entolimod reduces the adverse toxicity of TNF while preserving its antitumor effects von Haderski, Gary J, Kandar, Bojidar M, Brackett, Craig M, Toshkov, Ilia M, Johnson, Christopher P, Paszkiewicz, Geraldine M, Natarajan, Venkatesh, Gleiberman, Anatoli S, Gudkov, Andrei V, Burdelya, Lyudmila G

Volltext

Central role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonist von Burdelya, Lyudmila G., Brackett, Craig M., Kojouharov, Bojidar, Gitlin, Ilya I., Leonova, Katerina I., Gleiberman, Anatoli S., Aygun-Sunar, Semra, Veith, Jean, Johnson, Christopher, Haderski, Gary J., Stanhope-Baker, Patricia, Allamaneni, Shyam, Skitzki, Joseph, Zeng, Ming, Martsen, Elena, Medvedev, Alexander, Scheblyakov, Dmitry, Artemicheva, Nataliya M., Logunov, Denis Y., Gintsburg, Alexander L., Naroditsky, Boris S., Makarov, Sergei S., Gudkov, Andrei V.

Volltext

Anticancer drug candidate CBL0137, which inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide-responsive and -resistant glioblastoma von Barone, Tara A, Burkhart, Catherine A, Safina, Alfiya, Haderski, Gary, Gurova, Katerina V, Purmal, Andrei A, Gudkov, Andrei V, Plunkett, Robert J

Volltext

Preclinical Validation of a Single-Treatment Infusion Modality That Can Eradicate Extremity Melanomas von Kim, Minhyung, Neznanov, Nickolay, Wilfong, Chandler D, Fleyshman, Daria I, Purmal, Andrei A, Haderski, Gary, Stanhope-Baker, Patricia, Burkhart, Catherine A, Gurova, Katerina V, Gudkov, Andrei V, Skitzki, Joseph J

Volltext

Donor−Acceptor Complexes of Alkylcarbazole and Dicarbazolylalkane Donors with the Acceptors Tetracyanoethylene and Tetranitromethane von Haderski, Gary J, Chen, Zhenhua, Krafcik, Randolph B, Masnovi, John, Baker, Ronald J, Towns, Robert L. R

Volltext

Central role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonist von Burdelya, Lyudmila G., Brackett, Craig M., Kojouharov, Bojidar, Gitlin, Ilya I., Leonova, Katerina I., Gleiberman, Anatoli S., Aygun-Sunar, Semra, Veith, Jean, Johnson, Christopher, Haderski, Gary J., Stanhope-Baker, Patricia, Allamaneni, Shyam, Skitzki, Joseph, Zeng, Ming, Martsen, Elena, Medvedev, Alexander, Scheblyakov, Dmitry, Artemicheva, Nataliya M., Logunov, Denis Y., Gintsburg, Alexander L., Naroditsky, Boris S., Makarov, Sergei S., Gudkov, Andrei V.

Volltext

Abstract 4398: Liver is a major primary target for the Toll-like receptor-5 agonist CBLB502 providing radioprotective, antimicrobial and antitumor responses von Burdelya, Lyudmila, Leonova, Katerina, Gitlin, Ilya, Kojouharov, Bojidar, Aygun-Sunar, Semra, Veith, Jean, Johnson, Christopher, Gleiberman, Anatoli, Haderski, Gary, Allamaneni, Shyam, Skitzki, Joseph, Stanhope-Baker, Patricia, Scheblyakov, Dmitry, Logunov, Denis, Narodisky, Boris, Gudkov, Andrei

Volltext